Since no drugs are available to counteract Alzheimer's disease progression, today the research focus has shifted to nutraceutical compounds as an alternative form of prevention/treatment. The isothiocyanate sulforaphane (SF), abundant in Cruciferous vegetables, has received considerable attention because of its protective activity in different in vitro and in vivo animal models of neurodegeneration . Moreover, SF bioavailability in the central nervous system have been widely demonstrated . As no studies have been carried out to elucidate the effect of SF in counteracting glycative damage in neurons, we investigated the protective effects of SF against MG-induced glycative stress in neuroblastoma SH-SY5Y cells focusing on different intracellular targets.
Angeloni, C., Malaguti, M., Hrelia, S. (2015). Antiglycative activity of sulforaphane: A new avenue to counteract neurodegeneration?. NEURAL REGENERATION RESEARCH, 10(11), 1750-1751 [10.4103/1673-5374.169613].
Antiglycative activity of sulforaphane: A new avenue to counteract neurodegeneration?
ANGELONI, CRISTINA;MALAGUTI, MARCO;HRELIA, SILVANA
2015
Abstract
Since no drugs are available to counteract Alzheimer's disease progression, today the research focus has shifted to nutraceutical compounds as an alternative form of prevention/treatment. The isothiocyanate sulforaphane (SF), abundant in Cruciferous vegetables, has received considerable attention because of its protective activity in different in vitro and in vivo animal models of neurodegeneration . Moreover, SF bioavailability in the central nervous system have been widely demonstrated . As no studies have been carried out to elucidate the effect of SF in counteracting glycative damage in neurons, we investigated the protective effects of SF against MG-induced glycative stress in neuroblastoma SH-SY5Y cells focusing on different intracellular targets.File | Dimensione | Formato | |
---|---|---|---|
Neur Reg Res 2015.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Condividi allo stesso modo (CCBYNCSA)
Dimensione
383.42 kB
Formato
Adobe PDF
|
383.42 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.